Braun Aura 7 (6041)
Cyden Limited · Decision date Sep 30, 2026
What did the FDA decide?
FDA records K261975 as a 510(k) premarket notification, with a decision dated Sep 30, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 30, 2026
Regulatory record facts
- Identifier
- K261975
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Cyden Limited
- Product code
- OHT
- Decision code
- SESE
- Decision date
- Sep 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Light Based Over-The-Counter Hair Removal.
- Applicant
- Cyden Limited
- Product code
- OHT
- FDA device class
- 2
FDA decision timeline
K261975 received
Application receipt date recorded by FDA.
K261975 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code OHT
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ShenZhen Qiyue Trading Co., Ltd. | 510(k) clearance | Nov 3, 2026 | FDA | |
| Shenzhen Jianchao Intelligent Technology Co., Ltd. | 510(k) clearance | Oct 9, 2026 | FDA | |
Braun Aura 9 (6042)K261977 | Cyden Limited | 510(k) clearance | Sep 25, 2026 | FDA |
| ONE BEAUTY Technology Co., Ltd. | 510(k) clearance | Sep 18, 2026 | FDA | |
| Shenzhen Jianchao Intelligent Technology Co., Ltd. | 510(k) clearance | Aug 10, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cyden Limited
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Swansea
Sources and methodology
- Original FDA record: K261975
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



